Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-01-22 @ 2:58 PM
Study NCT ID:
NCT01265927
Status:
COMPLETED
Last Update Posted:
2015-10-27
First Post:
2010-12-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Sponsor:
Indiana University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Neoplasms | View |